Qnovia to Present at Gilmartin Group Private Company Showcase

RICHMOND, Va.–(BUSINESS WIRE)–Qnovia, Inc., a pharma company developing inhaled therapeutics across a variety of indication areas, announced today that Brian Quigley, CEO, will give a corporate presentation at Gilmartin Group’s inaugural virtual Spring Private Company Showcase. The company will present on Tuesday, April 18, 2023, at 4:00pm ET.

To attend the presentation, please register using this link.

About Qnovia, Inc.

Qnovia, Inc., formerly Respira Technologies, Inc., is a pharma company focused on developing and commercializing proprietary inhalation device technologies to improve patient outcomes. The company’s drug delivery platform is the first orientation-agnostic, portable vibrating mesh nebulizer that effectively operates in any position held by the patient. Qnovia sees significant opportunity to utilize its drug delivery technologies to improve the treatment of asthma, COPD, vaccine delivery, pain management, and several generic as well as select investigational new drugs. The company was founded by Mario Danek in 2018 to build cutting-edge drug delivery platforms that improve patient outcomes through superior device technologies. The company can be found at www.qnovia.com.

Contacts

Investor Relations:
Kiki Patel, PharmD

Gilmartin Group, Principal

[email protected]

Media Relations:
Richard Laermer

CEO

RLM Public Relations

212-741-5106 X 216

[email protected]

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Businesswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, businesswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.